A detailed history of Fifth Third Bancorp transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 11,227 shares of BIO stock, worth $3.07 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,227
Previous 9,509 18.07%
Holding current value
$3.07 Million
Previous $3.07 Million 26.48%
% of portfolio
0.02%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$304.11 - $351.99 $522,460 - $604,718
1,718 Added 18.07%
11,227 $3.88 Million
Q4 2023

Jan 19, 2024

SELL
$269.37 - $365.04 $1.02 Million - $1.38 Million
-3,793 Reduced 28.51%
9,509 $3.07 Million
Q3 2023

Oct 31, 2023

BUY
$350.25 - $422.63 $332,387 - $401,075
949 Added 7.68%
13,302 $4.77 Million
Q2 2023

Jul 25, 2023

BUY
$359.49 - $486.4 $511,913 - $692,633
1,424 Added 13.03%
12,353 $4.68 Million
Q1 2023

Apr 24, 2023

BUY
$418.69 - $503.0 $239,071 - $287,213
571 Added 5.51%
10,929 $5.24 Million
Q4 2022

Jan 25, 2023

BUY
$351.71 - $456.01 $335,179 - $434,577
953 Added 10.13%
10,358 $0
Q3 2022

Oct 25, 2022

BUY
$412.59 - $563.26 $920,900 - $1.26 Million
2,232 Added 31.12%
9,405 $3.92 Million
Q2 2022

Aug 04, 2022

BUY
$463.67 - $597.16 $113,135 - $145,707
244 Added 3.52%
7,173 $3.55 Million
Q1 2022

Apr 19, 2022

BUY
$524.57 - $735.42 $381,886 - $535,385
728 Added 11.74%
6,929 $3.9 Million
Q4 2021

Feb 01, 2022

SELL
$708.84 - $794.68 $107,743 - $120,791
-152 Reduced 2.39%
6,201 $4.69 Million
Q3 2021

Oct 15, 2021

BUY
$657.71 - $825.77 $657 - $825
1 Added 0.02%
6,353 $4.74 Million
Q2 2021

Aug 06, 2021

BUY
$576.64 - $649.04 $107,255 - $120,721
186 Added 3.02%
6,352 $4.09 Million
Q1 2021

May 07, 2021

BUY
$547.01 - $662.35 $280,069 - $339,123
512 Added 9.06%
6,166 $3.52 Million
Q4 2020

Feb 16, 2021

BUY
$510.68 - $643.45 $202,229 - $254,806
396 Added 7.53%
5,654 $3.3 Million
Q3 2020

Nov 09, 2020

BUY
$454.43 - $535.6 $56,349 - $66,414
124 Added 2.42%
5,258 $2.71 Million
Q2 2020

Aug 05, 2020

BUY
$334.87 - $493.06 $151,696 - $223,356
453 Added 9.68%
5,134 $2.32 Million
Q1 2020

May 05, 2020

BUY
$320.01 - $409.07 $164,485 - $210,261
514 Added 12.34%
4,681 $1.64 Million
Q4 2019

Feb 14, 2020

BUY
$319.73 - $374.2 $107,109 - $125,357
335 Added 8.74%
4,167 $1.54 Million
Q3 2019

Nov 14, 2019

SELL
$304.55 - $345.24 $28,627 - $32,452
-94 Reduced 2.39%
3,832 $1.28 Million
Q2 2019

Aug 07, 2019

SELL
$286.93 - $312.59 $22,667 - $24,694
-79 Reduced 1.97%
3,926 $1.23 Million
Q1 2019

May 14, 2019

SELL
$224.3 - $317.41 $20,411 - $28,884
-91 Reduced 2.22%
4,005 $1.22 Million
Q4 2018

Feb 14, 2019

BUY
$220.1 - $309.0 $23,770 - $33,372
108 Added 2.71%
4,096 $951,000
Q3 2018

Nov 14, 2018

BUY
$289.28 - $326.15 $15,910 - $17,938
55 Added 1.4%
3,988 $1.25 Million
Q2 2018

Aug 14, 2018

BUY
$244.1 - $303.88 $25,874 - $32,211
106 Added 2.77%
3,933 $1.14 Million
Q1 2018

May 15, 2018

SELL
$233.97 - $274.11 $94,757 - $111,014
-405 Reduced 9.57%
3,827 $957,000
Q4 2017

Feb 14, 2018

SELL
$216.94 - $271.3 $9,545 - $11,937
-44 Reduced 1.03%
4,232 $1.01 Million
Q3 2017

Nov 14, 2017

SELL
$212.27 - $242.28 $14,009 - $15,990
-66 Reduced 1.52%
4,276 $950,000
Q2 2017

Aug 11, 2017

BUY
N/A
4,342
4,342 $983,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $6.73B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.